Decitabine in the treatment of acute myeloid leukemia in elderly patients. - Wikidata - wikimedia - TriplyDB

Decitabine in the treatment of acute myeloid leukemia in elderly patients.

Decitabine in the treatment of acute myeloid leukemia in elderly patients.

http://www.wikidata.org/entity/Q37568244

about

Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies Physiological and pathological implications of 5-hydroxymethylcytosine in diseases Myeloid leukemia: are we getting better?The contributions of the European Medicines Agency and its pediatric committee to the fight against childhood leukemia TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes Acute depletion redefines the division of labor among DNA methyltransferases in methylating the human genome.Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis.Acute appendicitis in acute leukemia and the potential role of decitabine in the critically ill patient.SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.Low-dose hypomethylating agent decitabine in combination with aclacinomycin and cytarabine achieves a better outcome than standard FLAG chemotherapy in refractory/relapsed acute myeloid leukemia patients with poor-risk cytogenetics and mutations Vitamin C promotes decitabine or azacytidine induced DNA hydroxymethylation and subsequent reactivation of the epigenetically silenced tumour suppressor in colon cancer cells

P2860

Q26744080-FE8C019A-0CEF-4265-A0EF-886288FA1A8F Q26749375-3B3E2EB6-849C-4F0D-9EE1-75A0EFDAB478 Q35054842-86EFA944-A6BF-41A2-8E9A-D9C924764CB0 Q36267151-7C6E686B-9396-455F-AA41-C3CC6CEE60BA Q37566878-B7594219-9665-441A-8EB2-93F09BCEB413 Q38934393-BD96C5D8-F00B-4087-AB89-1FA856E2C5B1 Q39295844-268D28AF-C471-443D-BA78-039D2508CCDA Q39476734-D1D57178-E6B0-465A-9DCD-4D506233EB41 Q48821774-91B3F1B3-6B89-4891-AB14-64849237B5CB Q57815598-87202A4A-5AE2-4D28-BB99-BA1B81DCD6C0 Q58697697-485B7324-FC44-4E51-9C1A-EECD4DB95C76

P2860

Decitabine in the treatment of acute myeloid leukemia in elderly patients.

http://www.wikidata.org/entity/Q37568244

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Decitabine in the treatment of acute myeloid leukemia in elderly patients.

@en

Decitabine in the treatment of acute myeloid leukemia in elderly patients.

@nl

type

label

Decitabine in the treatment of acute myeloid leukemia in elderly patients.

@en

Decitabine in the treatment of acute myeloid leukemia in elderly patients.

@nl

prefLabel

Decitabine in the treatment of acute myeloid leukemia in elderly patients.

@en

Decitabine in the treatment of acute myeloid leukemia in elderly patients.

@nl

P1433

Q37568244-1020F2FA-4538-46F4-B18B-45D6792FB2CD

P1476

Q37568244-163F3A2D-34F8-4437-8B91-3134803F2E05

P2093

Q37568244-54396AAD-011F-492D-BC79-F433BEFBCE5A

Q37568244-624A7150-9373-4CBA-B1F6-78B31B5C2733

P2860

Q37568244-09DF7E1F-6BDC-4777-A2BB-1AEE9EBE6BB4

Q37568244-1C81A0FE-FBE0-415C-B9E1-76C94FF1910E

Q37568244-1C8AAEEE-9E57-442F-A113-F2E678534CB1

Q37568244-22A420B2-977C-44E4-B79B-6673BBE761EA

Q37568244-27AB0F8A-FFAF-4C10-BC9A-D7161E8AD11E

Q37568244-27C40FB0-008E-401E-8522-389777AB5EF4

Q37568244-2C5EDBFB-07FB-451C-934B-B6007CB35D16

Q37568244-2FE5E624-732C-4DB1-8D74-EA5016FF891E

Q37568244-322E3F02-9844-4975-89E0-069C179369C1

Q37568244-35BE2238-26C2-4DDD-BE8F-D90DDB047570

P304

Q37568244-FB4F8AC9-AD0C-4D51-8CA1-B8DA0331A99E

P31

Q37568244-8DF2D65A-B78A-442F-901E-C9168896E70C

P356

Q37568244-B176044A-C5CB-422E-8160-E18FE7FFFDD1

P407

Q37568244-92FEFA8C-EC30-4BA6-8C4C-4AC53AB00453

P478

Q37568244-2F29FA3C-30AD-4DDC-BA13-A0C67E1458C4

P577

Q37568244-F13853D4-9831-446B-B120-8C7012521C8C

P5875

Q37568244-4F97AEB0-21D9-49EA-950B-70DC23023F17

P698

Q37568244-CFD2099D-4AF6-4488-9E68-72BCEA36F1EC

P921

Q37568244-161C7279-2118-4DB3-8C5B-60637D8FE6F9

P932

Q37568244-1C4BFEAE-449F-483A-A529-D19C64B46694

P356

P1433

Cancer Management and Research

P1476

Decitabine in the treatment of acute myeloid leukemia in elderly patients.

@en

P2093

Amanda F Cashen

http://www.w3.org/2001/XMLSchema#string

Priya Malik

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia.

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

Gene silencing in cancer in association with promoter hypermethylation

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.

Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

Azacitidine: a review of its use in the management of myelodysplastic syndromes/acute myeloid leukaemia.

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

P304

53-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CMAR.S40600

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260150345

http://www.w3.org/2001/XMLSchema#string

P698

24520204

http://www.w3.org/2001/XMLSchema#string

P921

P932

3917925

http://www.w3.org/2001/XMLSchema#string